Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Celldex Therapeutics Inc (NASDAQ: CLDX) closed at $20.35 in the last session, up 0.30% from day before closing price of $20.29. In other words, the price has increased by $0.30 from its previous closing price. On the day, 1.45 million shares were traded. CLDX stock price reached its highest trading level at $20.485 during the session, while it also had its lowest trading level at $19.52.
Ratios:
We take a closer look at CLDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.67 and its Current Ratio is at 21.67. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on April 28, 2025, initiated with a Buy rating and assigned the stock a target price of $64.
On March 20, 2025, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $46.
On February 13, 2025, UBS started tracking the stock assigning a Buy rating and target price of $44.UBS initiated its Buy rating on February 13, 2025, with a $44 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 11 ’24 when Marucci Anthony S bought 11,500 shares for $26.82 per share. The transaction valued at 308,430 led to the insider holds 40,284 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLDX now has a Market Capitalization of 1351122048 and an Enterprise Value of 681259776. For the stock, the TTM Price-to-Sale (P/S) ratio is 178.72 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 90.126 whereas that against EBITDA is -3.184.
Stock Price History:
The Beta on a monthly basis for CLDX is 1.13, which has changed by -0.45014858 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, CLDX has reached a high of $47.00, while it has fallen to a 52-week low of $14.40. The 50-Day Moving Average of the stock is 1.18%, while the 200-Day Moving Average is calculated to be -15.90%.
Shares Statistics:
According to the various share statistics, CLDX traded on average about 977.05K shares per day over the past 3-months and 1127940 shares per day over the past 10 days. A total of 66.38M shares are outstanding, with a floating share count of 64.51M. Insiders hold about 2.84% of the company’s shares, while institutions hold 109.39% stake in the company. Shares short for CLDX as of 1749772800 were 7828519 with a Short Ratio of 8.01, compared to 1747267200 on 9127147. Therefore, it implies a Short% of Shares Outstanding of 7828519 and a Short% of Float of 13.930000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
